Genprex Capital Surpluse vs Other Current Liab Analysis

GNPX Stock

USD 2.18 0.03 1.36%

Genprex financial indicator trend analysis is much more than just examining Genprex latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genprex is a good investment. Please check the relationship between Genprex Capital Surpluse and its Other Current Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genprex. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Capital Surpluse vs Other Current Liab

Capital Surpluse vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genprex Capital Surpluse account and Other Current Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between Genprex's Capital Surpluse and Other Current Liab is 0.77. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Genprex, assuming nothing else is changed. The correlation between historical values of Genprex's Capital Surpluse and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Genprex are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Capital Surpluse i.e., Genprex's Capital Surpluse and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.77

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Capital Surpluse

Other Current Liab

Most indicators from Genprex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genprex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genprex. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.At this time, Genprex's Issuance Of Capital Stock is fairly stable compared to the past year. Enterprise Value is likely to rise to about 8.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 12.8 K in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	22.5K	25.6K	17.7K	17.4K
Interest Income	5.1K	90.1K	231.0K	242.6K

Reconciled Depreciation Interest Income

Genprex fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Net Receivables
Total Assets		0.43	0.5	1.0	0.78	0.75	-0.99	-0.62	0.46	1.0	0.74	0.68	0.14	1.0	0.79	-0.74	0.8	0.65	0.81	0.5	0.7	1.0	0.77	0.88	0.72	-0.03
Other Current Liab	0.43		0.96	0.38	0.82	0.1	-0.33	-0.88	0.76	0.39	0.79	0.85	-0.01	0.39	0.78	-0.61	0.77	0.82	0.76	0.96	0.66	0.38	0.75	0.32	0.73	0.33
Total Current Liabilities	0.5	0.96		0.45	0.9	0.19	-0.38	-0.96	0.89	0.45	0.83	0.9	-0.09	0.45	0.87	-0.72	0.86	0.93	0.82	1.0	0.77	0.45	0.81	0.29	0.84	0.08
Total Stockholder Equity	1.0	0.38	0.45		0.74	0.76	-0.99	-0.58	0.42	1.0	0.69	0.64	0.15	1.0	0.76	-0.71	0.76	0.62	0.77	0.45	0.67	1.0	0.73	0.88	0.68	-0.05
Net Tangible Assets	0.78	0.82	0.9	0.74		0.41	-0.69	-0.97	0.82	0.75	0.85	0.88	-0.04	0.75	0.97	-0.83	0.98	0.97	0.93	0.9	0.84	0.75	0.89	0.52	0.9	-0.05
Property Plant And Equipment Net	0.75	0.1	0.19	0.76	0.41		-0.77	-0.35	0.27	0.75	0.45	0.31	0.19	0.75	0.57	-0.7	0.55	0.37	0.57	0.19	0.72	0.76	0.66	0.84	0.65	-0.18
Net Debt	-0.99	-0.33	-0.38	-0.99	-0.69	-0.77		0.52	-0.35	-0.99	-0.69	-0.61	-0.15	-0.99	-0.71	0.66	-0.71	-0.55	-0.75	-0.38	-0.62	-0.99	-0.71	-0.9	-0.63	0.0
Retained Earnings	-0.62	-0.88	-0.96	-0.58	-0.97	-0.35	0.52		-0.88	-0.58	-0.82	-0.87	0.09	-0.58	-0.95	0.84	-0.95	-0.98	-0.91	-0.96	-0.87	-0.58	-0.9	-0.4	-0.93	0.05
Accounts Payable	0.46	0.76	0.89	0.42	0.82	0.27	-0.35	-0.88		0.43	0.73	0.81	0.02	0.43	0.82	-0.68	0.81	0.89	0.72	0.89	0.76	0.42	0.75	0.18	0.82	-0.31
Cash	1.0	0.39	0.45	1.0	0.75	0.75	-0.99	-0.58	0.43		0.71	0.65	0.13	1.0	0.76	-0.7	0.76	0.62	0.77	0.45	0.67	1.0	0.73	0.87	0.68	-0.03
Non Current Assets Total	0.74	0.79	0.83	0.69	0.85	0.45	-0.69	-0.82	0.73	0.71		0.96	-0.07	0.71	0.81	-0.72	0.8	0.77	0.91	0.83	0.7	0.69	0.85	0.62	0.77	0.19
Non Currrent Assets Other	0.68	0.85	0.9	0.64	0.88	0.31	-0.61	-0.87	0.81	0.65	0.96		-0.13	0.65	0.82	-0.69	0.81	0.83	0.84	0.9	0.68	0.63	0.77	0.49	0.77	0.15
Other Assets	0.14	-0.01	-0.09	0.15	-0.04	0.19	-0.15	0.09	0.02	0.13	-0.07	-0.13		0.13	0.13	-0.04	0.05	-0.08	0.0	-0.09	0.04	0.16	0.1	0.28	-0.02	-0.12
Cash And Short Term Investments	1.0	0.39	0.45	1.0	0.75	0.75	-0.99	-0.58	0.43	1.0	0.71	0.65	0.13		0.76	-0.7	0.76	0.62	0.77	0.45	0.67	1.0	0.73	0.87	0.68	-0.03
Common Stock Total Equity	0.79	0.78	0.87	0.76	0.97	0.57	-0.71	-0.95	0.82	0.76	0.81	0.82	0.13	0.76		-0.9	1.0	0.95	0.93	0.87	0.93	0.77	0.95	0.61	0.96	-0.11
Common Stock Shares Outstanding	-0.74	-0.61	-0.72	-0.71	-0.83	-0.7	0.66	0.84	-0.68	-0.7	-0.72	-0.69	-0.04	-0.7	-0.9		-0.9	-0.82	-0.86	-0.72	-0.94	-0.72	-0.91	-0.65	-0.94	0.15
Capital Surpluse	0.8	0.77	0.86	0.76	0.98	0.55	-0.71	-0.95	0.81	0.76	0.8	0.81	0.05	0.76	1.0	-0.9		0.96	0.94	0.86	0.93	0.77	0.94	0.59	0.96	-0.12
Other Current Assets	0.65	0.82	0.93	0.62	0.97	0.37	-0.55	-0.98	0.89	0.62	0.77	0.83	-0.08	0.62	0.95	-0.82	0.96		0.88	0.93	0.88	0.62	0.87	0.38	0.92	-0.17
Other Stockholder Equity	0.81	0.76	0.82	0.77	0.93	0.57	-0.75	-0.91	0.72	0.77	0.91	0.84	0.0	0.77	0.93	-0.86	0.94	0.88		0.82	0.86	0.77	0.97	0.67	0.9	0.03
Total Liab	0.5	0.96	1.0	0.45	0.9	0.19	-0.38	-0.96	0.89	0.45	0.83	0.9	-0.09	0.45	0.87	-0.72	0.86	0.93	0.82		0.77	0.45	0.81	0.29	0.84	0.08
Property Plant And Equipment Gross	0.7	0.66	0.77	0.67	0.84	0.72	-0.62	-0.87	0.76	0.67	0.7	0.68	0.04	0.67	0.93	-0.94	0.93	0.88	0.86	0.77		0.68	0.94	0.6	0.99	-0.17
Total Current Assets	1.0	0.38	0.45	1.0	0.75	0.76	-0.99	-0.58	0.42	1.0	0.69	0.63	0.16	1.0	0.77	-0.72	0.77	0.62	0.77	0.45	0.68		0.74	0.88	0.69	-0.05
Intangible Assets	0.77	0.75	0.81	0.73	0.89	0.66	-0.71	-0.9	0.75	0.73	0.85	0.77	0.1	0.73	0.95	-0.91	0.94	0.87	0.97	0.81	0.94	0.74		0.68	0.95	-0.03
Common Stock	0.88	0.32	0.29	0.88	0.52	0.84	-0.9	-0.4	0.18	0.87	0.62	0.49	0.28	0.87	0.61	-0.65	0.59	0.38	0.67	0.29	0.6	0.88	0.68		0.58	0.25
Property Plant Equipment	0.72	0.73	0.84	0.68	0.9	0.65	-0.63	-0.93	0.82	0.68	0.77	0.77	-0.02	0.68	0.96	-0.94	0.96	0.92	0.9	0.84	0.99	0.69	0.95	0.58		-0.14
Net Receivables	-0.03	0.33	0.08	-0.05	-0.05	-0.18	0.0	0.05	-0.31	-0.03	0.19	0.15	-0.12	-0.03	-0.11	0.15	-0.12	-0.17	0.03	0.08	-0.17	-0.05	-0.03	0.25	-0.14

Click cells to compare fundamentals

Genprex Account Relationship Matchups

Genprex fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.5M	31.4M	42.9M	25.1M	10.7M	15.4M
Other Current Liab	74.4K	257.8K	612.1K	2.4M	1.9M	1.9M
Total Current Liabilities	510.7K	450.7K	1.6M	2.8M	3.3M	3.4M
Total Stockholder Equity	3.0M	30.9M	41.3M	22.3M	7.4M	14.2M
Net Tangible Assets	8.5M	2.5M	30.3M	40.6M	46.7M	49.1M
Property Plant And Equipment Net	44.7K	39.4K	48.6K	23.0K	7.9K	7.5K
Net Debt	(2.0M)	(27.3M)	(38.6M)	(21.0M)	(6.7M)	(7.1M)
Retained Earnings	(40.5M)	(58.4M)	(78.0M)	(102.8M)	(133.7M)	(127.0M)
Accounts Payable	436.3K	193.0K	973.2K	442.9K	1.4M	1.5M
Cash	2.0M	27.3M	38.6M	21.0M	6.7M	13.0M
Non Current Assets Total	557.6K	651.8K	3.7M	3.6M	3.1M	1.7M
Non Currrent Assets Other	21.7K	10.7K	3.0M	2.9M	2.4M	2.5M
Other Assets	21.7K	612.4K	0.0	1.0	0.9	0.86
Cash And Short Term Investments	2.0M	27.3M	38.6M	21.0M	6.7M	13.0M
Common Stock Total Equity	11.7K	15.2K	19.3K	43.1K	49.6K	52.1K
Common Stock Shares Outstanding	400.7K	888.1K	1.2M	1.2M	1.4M	1.3M
Liabilities And Stockholders Equity	3.5M	31.4M	42.9M	25.1M	10.7M	15.4M
Capital Surpluse	17.9M	38.7M	43.5M	89.3M	102.7M	107.8M
Other Current Assets	171.7K	384.6K	511.3K	484.2K	794.1K	833.8K
Other Stockholder Equity	43.5M	89.3M	119.2M	125.1M	141.1M	73.4M
Total Liab	510.7K	450.7K	1.6M	2.8M	3.3M	3.4M
Property Plant And Equipment Gross	7.8K	24.4K	44.7K	39.4K	45.4K	47.6K
Total Current Assets	3.0M	30.7M	39.1M	21.5M	7.5M	13.8M
Intangible Assets	491.2K	601.6K	642.4K	702.1K	773.5K	523.9K
Common Stock	19.3K	43.1K	47.9K	48.1K	1.5K	1.4K
Property Plant Equipment	24.4K	44.7K	39.4K	48.6K	55.9K	58.7K
Net Receivables	8.8K	9.3K	655.0	127.0	0.0	34.9K
Net Invested Capital	3.0M	30.9M	41.3M	22.3M	7.4M	7.0M
Net Working Capital	2.5M	30.3M	37.6M	18.7M	4.3M	4.1M
Capital Stock	19.3K	43.1K	47.9K	48.1K	1.5K	1.4K

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genprex in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genprex's short interest history, or implied volatility extrapolated from Genprex options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Genprex offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genprex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genprex Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genprex Stock:

How To Invest In Genprex

Details

Is Genprex Stock a good investment?

Details

What is Genprex's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genprex. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Genprex Stock analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.

	Fundamental Analysis View fundamental data based on most recent published financial statements
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account

Is Genprex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genprex. If investors know Genprex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genprex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(22.56)

Return On Assets

(1.09)

Return On Equity

(2.08)

The market value of Genprex is measured differently than its book value, which is the value of Genprex that is recorded on the company's balance sheet. Investors also form their own opinion of Genprex's value that differs from its market value or its book value, called intrinsic value, which is Genprex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genprex's market value can be influenced by many factors that don't directly affect Genprex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Genprex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genprex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genprex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Genprex Capital Surpluse vs Other Current Liab Analysis

Capital Surpluse vs Other Current Liab

Capital Surpluse vs Other Current Liab Correlation Analysis

Correlation Coefficient

Capital Surpluse

Other Current Liab

Genprex fundamental ratios Correlations

Genprex Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Genprex fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Genprex Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash	+ 1.0	Total Stockholder Equity

Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.99	Total Assets
Other Current Assets	- 0.98	Retained Earnings